Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04369950 · ClinicalTrials.gov registry record · Phase 4
Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 44
- Enrollment target
NCT04369950: Completed Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
NCT04369950 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 44 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04369950, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this study is to show that the effect of 3% 2-chloroprocaine prior to epidural morphine administration will be not inferior to the effect of epidural 2% lidocaine with 1:200,000 epinephrine on total opioid use for 24h
Interventions
- DRUG 2% lidocaine with 1:200,000 epinephrine and epidural morphine
- DRUG 3% 2-chloroprocaine and epidural morphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2020-05-11 |
| Est. Completion | 2021-07-11 |
| Phase | Phase 4 |
What the finished NCT04369950 record still lists
NCT04369950 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which 2% lidocaine with 1:200,000 epinephrine and epidural morphine is the first listed.
NCT04369950 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04369950 about?
NCT04369950 is a clinical study titled "Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine". The purpose of this study is to show that the effect of 3% 2-chloroprocaine prior to epidural morphine administration will be not inferior to the effect of epidural 2% lidocaine with 1:200,000 epinephrine on total opioid use for 24h
What is the current status of trial NCT04369950?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 44 participants. The study started on 2020-05-11. Estimated completion is 2021-07-11.
What interventions are being tested in trial NCT04369950?
The interventions under investigation include: 2% lidocaine with 1:200,000 epinephrine and epidural morphine (DRUG), 3% 2-chloroprocaine and epidural morphine (DRUG).
Who is sponsoring clinical trial NCT04369950?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04369950's enrollment target sits among peer trials
44 1363rd of 2000 higher than 630 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI